USPTO Says Group Lacks Standing In Stem Cell Patent Appeal

Law360, New York (January 23, 2014, 5:33 PM ET) -- The U.S. Patent and Trademark Office told the Federal Circuit last week that parties without a "concrete" interest in a patent cannot appeal USPTO review decisions, urging the court to toss an appeal by a consumer group challenging the validity of a stem cell patent.

In an amicus brief filed Jan. 17 and made public Thursday, the agency noted that anyone can seek to have the validity of patents re-examined in USPTO proceedings, but argued that only those that have suffered some injury have standing under...
To view the full article, register now.

DEWEY LIVE BLOG

Follow our exclusive coverage of the trial of the year:

Catch up on the Dewey trial here